<p>A. SiCo and uPARsi human VSMC were treated with 1.2(A) and serine phosphorylation (B) was assessed using Duolink proximity ligation assay. The right panels show the number of Duolink PLA signals per cell quantified using ImageJ software. DraQ5 was used as nuclear stain. C. Serine phosphorylation of PSMD6 was assessed by immunoprecipitation. PSMD6 from lysates of control and MMS-stimulated cells was immunoprecipitated. P-Ser was detected by western blotting. The lower panel shows loading controls.</p
The expression of the urokinase-type plasminogen activator (uPA) and its receptor (uPAR) can be regu...
The expression of the urokinase-type plasminogen activator (uPA) and its receptor (uPAR) can be regu...
The expression of the urokinase-type plasminogen activator (uPA) and its receptor (uPAR) can be regu...
<p>A. SiCo and uPARsi human VSMC were treated with 1.2(B) and uPARsi (C) VSMC were treated with 1.2 ...
<p>A. Growth arrested SiCo and uPARsi -nucleofected human VSMC were treated with 1.2 mM MMS for indi...
<p>VSMC were incubated with Tn (5 µg/ml), MG132 (1 µM) or their combination for 16 h. Total cell hom...
<p>IL-6 (panel A) and CCL5 (panel B): production by LNCaP cells left untreated (open bars), stimulat...
<p>The NCI-H929 MM cell line was transfected with the PERK (A, B), ATF6 (C), IRE1 (D) or non-targeti...
<p>Tet-inducible K562 cells were electroporated as in <a href="http://www.plosone.org/article/info:d...
<p>A. SiCo and uPARsi -nucleofected human VSMC were treated with 100 µM H<sub>2</sub>O<sub>2</sub> f...
<p>(A) Western blot analysis of UPF1, UPF2 and UPF3b protein expression in MM6 cells with and withou...
The cellular receptor for urokinase plasminogen activator (uPA-R) is a monomeric phosphatidylinosito...
The expression of the urokinase-type plasminogen activator (uPA) and its receptor (uPAR) can be regu...
The expression of the urokinase-type plasminogen activator (uPA) and its receptor (uPAR) can be regu...
<p>(A) Wild-type and BMPR2<sup>+/−</sup> PSCs were treated with 250 ng/ml of BMP2 for the indicated ...
The expression of the urokinase-type plasminogen activator (uPA) and its receptor (uPAR) can be regu...
The expression of the urokinase-type plasminogen activator (uPA) and its receptor (uPAR) can be regu...
The expression of the urokinase-type plasminogen activator (uPA) and its receptor (uPAR) can be regu...
<p>A. SiCo and uPARsi human VSMC were treated with 1.2(B) and uPARsi (C) VSMC were treated with 1.2 ...
<p>A. Growth arrested SiCo and uPARsi -nucleofected human VSMC were treated with 1.2 mM MMS for indi...
<p>VSMC were incubated with Tn (5 µg/ml), MG132 (1 µM) or their combination for 16 h. Total cell hom...
<p>IL-6 (panel A) and CCL5 (panel B): production by LNCaP cells left untreated (open bars), stimulat...
<p>The NCI-H929 MM cell line was transfected with the PERK (A, B), ATF6 (C), IRE1 (D) or non-targeti...
<p>Tet-inducible K562 cells were electroporated as in <a href="http://www.plosone.org/article/info:d...
<p>A. SiCo and uPARsi -nucleofected human VSMC were treated with 100 µM H<sub>2</sub>O<sub>2</sub> f...
<p>(A) Western blot analysis of UPF1, UPF2 and UPF3b protein expression in MM6 cells with and withou...
The cellular receptor for urokinase plasminogen activator (uPA-R) is a monomeric phosphatidylinosito...
The expression of the urokinase-type plasminogen activator (uPA) and its receptor (uPAR) can be regu...
The expression of the urokinase-type plasminogen activator (uPA) and its receptor (uPAR) can be regu...
<p>(A) Wild-type and BMPR2<sup>+/−</sup> PSCs were treated with 250 ng/ml of BMP2 for the indicated ...
The expression of the urokinase-type plasminogen activator (uPA) and its receptor (uPAR) can be regu...
The expression of the urokinase-type plasminogen activator (uPA) and its receptor (uPAR) can be regu...
The expression of the urokinase-type plasminogen activator (uPA) and its receptor (uPAR) can be regu...